SIM
IRWD icon

Spark Investment Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

Spark Investment Management’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-142,444
Closed -$2.25M – 757
2017
Q2 		$2.25M Sell
142,444
-453,601
-76% -$6.59M 0.14% 226
2017
Q1 		$8.52M Hold
596,045
– – 0.54% 28
2016
Q4 		$7.63M Sell
596,045
-82,266
-12% -$1.04M 0.63% 20
2016
Q3 		$9.02M Buy
678,311
+265,068
+64% +$3.1M 0.73% 11
2016
Q2 		$4.53M Buy
413,243
+177,070
+75% +$1.73M 0.42% 48
2016
Q1 		$2.16M Buy
236,173
+103,997
+79% +$858K 0.22% 142
2015
Q4 		$1.28M Buy
132,176
+74,148
+128% +$717K 0.16% 190
2015
Q3 		$505K Sell
58,028
-190,802
-77% -$1.78M 0.07% 374
2015
Q2 		$2.51M Buy
+248,830
New +$2.89M 0.35% 77

Other funds holding IRWD

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Spark Investment Management's IRWD Position: Q3 2017 in Review

Spark Investment Management sold out of Ironwood Pharmaceuticals (IRWD) in Q3 2017, closing a stake of 142,444 shares — an estimated $2.25M sold.

Spark Investment Management first reported a position in IRWD in Q2 2015 and held it in 9 quarters. The position peaked at $9.02M in Q3 2016. 149 funds tracked by Wall St. Rank hold IRWD as of Q3 2017.

  • Spark Investment Management reported no remaining Ironwood Pharmaceuticals position as of Q3 2017 after selling out during the quarter.
  • Spark Investment Management sold 142,444 Ironwood Pharmaceuticals shares in Q3 2017, an estimated $2.25M.
  • Spark Investment Management first reported a position in Ironwood Pharmaceuticals in Q2 2015 and held it in 9 quarters.
  • Spark Investment Management's Ironwood Pharmaceuticals position peaked at $9.02M in Q3 2016.
  • 149 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q3 2017.

Based on Spark Investment Management's 13F filing for Q3 2017, filed 13 Nov 2017.